Rockville, Md. − The future of clinical ophthalmology may be endangered by the decline in the number of human donor eyes provided by U.S. eye banks according to an article published in the July 2006 issue of Investigative Ophthalmology & Visual Science (IOVS).
According to a survey of U.S. members of the Association for Research in Vision and Ophthalmology (ARVO), the major prohibitory factor in the use of human eye tissue is lack of availability of tissue meeting stringent criteria. The survey's conductor, Christine A. Curcio, PhD, of ARVO's Research Tissue Acquisition Working Group (RTAWG), found that only cost exceeded this factor among those surveyed. Respondents also indicated that local eye banks are the most common tissue source although most investigators use multiple tissues sources, including remote eye banks to acquire adequate human eye tissue needed for research.
The availability of human eye tissue for research has been severely impacted by federal regulations and state laws enacted over the last decade, and some individual eye bank practices may be of importance on a local level (e.g., laws prohibiting medical examiners from releasing eye tissue in cases of violent or suspicious death).
The RTAWG believes that the decline in human research tissue may be managed in the short term by researchers working closely with eye banks and other providers, communicating on a regular basis, and clarifying their experimental needs and expectations.
"No where do impediments to obtaining human eyes for research have more impact than in the effort to understand age-related macular degeneration, the leading cause of new vision loss in the elderly," said Curcio, a professor of ophthalmology at the University of Alabama at Birmingham. "Macular degeneration, an advanced form of which now has treatment options, still lacks a laboratory animal model that displays the full range of pathology typifying the human disorder. Thus, human tissues are particularly critical."
Read this article online at http://www.iovs.org/cgi/content/full/47/7/2747.
IOVS is published by the Association for Research in Vision and Ophthalmology (ARVO). For more information, logon to www.IOVS.org.
ARVO is a membership organization of more than 11,500 eye and vision researchers from over 70 countries. Established in 1928, the Association encourages and assists its members and others in research, training, publication and dissemination of knowledge in vision and ophthalmology. ARVO's headquarters are located in Rockville, Md. For more information about ARVO, logon to www.arvo.org.
Journal
Investigative Ophthalmology & Visual Science